Intelligent NR
Canon Inc. • Radiology • 09/17/2021
Device Purpose
The Intelligent NR function is a software component for Canon's radiography systems, utilizing a pre-trained machine learning algorithm to reduce noise and enhance image quality in digital X-ray images. This technology aims to improve diagnostic capabilities in general radiographic procedures by processing images based on learned noise characteristics from a clinical database, without ongoing machine learning in the field.
Summary
The Intelligent NR (Intelligent Noise Reduction) is a software function integrated within Canon's CXDI Control Software (version 3.10) designed to reduce noise in X-ray images acquired using compatible Canon detectors. This function operates on a PC and displays images on a monitor. The core technology relies on a machine-learning algorithm that was trained using an existing clinical image database to identify and learn the characteristics of various noises present in X-ray images, enabling it to generate noise-reduced images. Importantly, the machine learning model does not undergo further training or adaptation after its release to users. The firmware within the compatible Canon detectors remains unchanged and requires no updates for use with the Intelligent NR function. The intended use for the CXDI Control Software with the Intelligent NR function is to provide digital image capture, processing, and display for conventional film/screen radiographic examinations, acting as a replacement for traditional systems. It is applicable across general-purpose diagnostic procedures, including specialized areas such as intensive care, trauma, and pediatric work. However, it is not intended for use in fluoroscopic, angiographic, or mammography applications. The hardware of the Canon Digital Radiography detectors used with this software has not been modified, ensuring that their performance, biocompatibility, effectiveness, and safety profiles remain consistent with previously established standards. Risk analysis using FMEA methodology was conducted, and identified risks were mitigated through design controls.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How was the 'existing clinical image database' used for training the Intelligent NR algorithm curated, and what measures were taken to ensure its diversity and representativeness of various patient populations and imaging conditions?; What specific types of noise (e.g., quantum mottle, electronic noise) does the Intelligent NR function primarily target, and how does its performance vary across different X-ray exposure levels and anatomical regions?; Are there quantifiable metrics available to demonstrate the degree of noise reduction achieved by Intelligent NR without compromising diagnostic image quality or introducing artifacts, compared to images processed without this function?; Given that the machine learning model is static after release, what is the anticipated lifespan of its effectiveness before potential retraining might be considered due to evolving imaging practices or detector technology?; How does the Intelligent NR function affect image sharpness and the visibility of subtle pathologies compared to raw or conventionally processed images, and were studies conducted to specifically assess this impact on diagnostic accuracy?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SBOM, ML-BOM, HBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SaaSBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly